Vericel Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you for joining us today for the JPMorgan Healthcare Conference. My name is James Austin, and I'm an associate in JPMorgan's Healthcare Investment Banking team.
Before I introduce you to our presenter today, I want to call your attention to the blue button on your screen. This is where you'll submit questions to be addressed after the presentation. With that covered, I'm excited to introduce you to Nick Colangelo, CEO of Vericel. Nick, I'll go ahead and hand it over to you.
All right, James. Well, thank you very much. We really appreciate the opportunity to be presenting and kicking off bright and early on day 3 of the JPMorgan Conference.
So before I begin, I'd like to remind listeners that this presentation contains forward-looking statements and you should refer to documents on file with the SEC for further information.
So for those of you who are not as familiar with Vericel, we are a leader in advanced therapies for the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |